the detection and management of mnts following bcma-directed car-t therapy
Published 7 months ago • 84 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
1:43
management of car-t related side effects
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
3:01
mechanisms of antigen escape following cd19-directed car-t therapy
-
3:07
the role of bridging and timing in car-t
-
11:34
chimeric antigen receptor car technique - creative biolabs (updated version)
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
5:01
b cells vs t cells | b lymphocytes vs t lymphocytes - adaptive immunity - mechanism
-
1:13
monitoring patients with cll on ibrutinib-based therapies
-
0:59
identifying molecular markers for the prediction of icaht in patients receiving car t-cell therapy
-
1:16
the efficacy of car t-cell therapy in richter's transformation
-
1:14
components of the car-hematotox model which allow for prediction of icaht following car-t
-
1:35
key mechanisms of resistance to car t-cell therapy
-
1:39
exploring the applications of car-ts beyond hematology and oncology
-
1:55
unmet needs in dlbcl: frontline therapy, car-t optimization, and clinical trial inclusion
-
1:52
single-cell and immune sequencing to predict response and resistance to car-t therapy in r/r mm
-
1:26
ebmt guidelines car-t education & guidelines for nurses
-
1:52
perspectives on patient selection for car-t therapy
-
1:39
the role of myeloid cells in car-t cell therapy
-
1:18
the role of social media in the development of car-t therapy